📰 Comparative Effectiveness News
Comparative Effectiveness News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Comparative Effectiveness. Real-time updates on events, politics, business and more.
March 26, 2024
UAB researchers say the presented data indicates that a younger age and higher HbA1c at baseline predict early treatment failure and point to the need for more aggressive initial treatment in these patients. University o...
February 6, 2024
Investigators found patients receiving chemotherapy had a greater risk of a secondary primary malignancy (SPM) compared with those treated with targeted therapies or those whose chronic lymphocytic leukemia (CLL) was left untreated.
January 17, 2024
The efficacy of antidepressant medication management (MEDS) against behavioral activation psychotherapy (BA).
December 6, 2023
Drug's novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional status.
November 28, 2023
SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders and oncology, will present data on cenobamate at the American Epilepsy Society (AES) Annual Meeting, to be held December 1-5, 2023, in Orlando, Florida.
October 17, 2023
In the absence of a randomized comparison trial on fracture risk reduction, researchers use negative control outcome to compare the two drugs.
October 13, 2023
Looking for the best fat burning cream on the market? Read on to check out the best fat-burning creams for 2023.
September 26, 2023
Adjuvant therapy, instead of just surgery alone, for early-stage non-small-cell lung cancer (NSCLC) after surgery incurs lower medical costs than surgery alone.
September 21, 2023
/PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of...
September 19, 2023
1. In this cross-sectional study, the proportion of Chinese adults with self-reported type 2 diabetes who achieved a guideline-recommended HbA1c target was 64.1%. 2. The proportion of Chinse adults with self-reported type 2 diabetes who achieved a guideline-recommended blood pressure was 22.2%. Evidence Rating Level: 1 (Excellent) Study Rundown: More than one-quarter of the Chinese